Tectonic Therapeutic IncQ) expected to post a loss of $1.03 a share - Earnings Preview
Tectonic Therapeutic IncQ) is projected to report a loss of $1.03 per share for the quarter ending September 30, 2025, with no change in revenue. Analysts maintain a "buy" rating, with a median 12-month price target of $80.50, significantly above its last closing price of $21.92. Recent earnings estimates have increased by 3.3% over the past three months. Previous quarterly performances show mixed results, with several misses and beats in earnings expectations.
- Tectonic Therapeutic Inc (TECX.OQ) (TECX.O) is expected to
show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending September 30 2025
- LSEG’s mean analyst estimate for Tectonic Therapeutic Inc is for a loss of $1.03 per share.
- The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 8 “strong buy” or “buy,” no “hold” and no “sell” or “strong sell.”
- The mean earnings estimate of analysts had risen by about 3.3% in the last three months.
- Wall Street’s median 12-month price target for Tectonic Therapeutic Inc is $80.50, about 72.8% above its last closing price of $21.92 Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2025 -0.96 -0.98 -1.07 Missed -9
Mar. 31 2025 -1.09 -1.09 -0.93 Beat 14.9
Dec. 31 2024 -1.39 -0.84 Beat 39.4
Sep. 30 2024 -0.82 -0.82 -1.20 Missed -45.5
Jun. -1.40 -1.50 -4.34 Missed -189.3
30 2024
Mar. 31 2024 -4.32 -4.32 -1.80 Beat 58.3
Dec. 31 2023 -4.95 -4.04 -2.40 Beat 40.6
Sep. 30 2023 -3.34 -3.40 -5.28 Missed -55.3
This summary was machine generated August 8 at 11:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
